These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8185774)

  • 1. Vaccine prospects for dengue haemorrhagic fever.
    World Health Forum; 1993; 14(2):203. PubMed ID: 8185774
    [No Abstract]   [Full Text] [Related]  

  • 2. Dengue vaccine.
    Simasathien S; Watanaveeradej V
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue fever climbs the social ladder.
    Nature; 2007 Aug; 448(7155):734-5. PubMed ID: 17700664
    [No Abstract]   [Full Text] [Related]  

  • 4. Technology evaluation: ChimeriVax-DEN, Acambis/Aventis.
    Jones T
    Curr Opin Mol Ther; 2004 Aug; 6(4):443-50. PubMed ID: 15468603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Future prospects in developing of dengue vaccines].
    Valero N; Levy A
    Invest Clin; 2008 Jun; 49(2):135-8. PubMed ID: 18717261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of dengue vaccines: an overview.
    Kanesa-thasan N
    Indian Pediatr; 1998 Feb; 35(2):97-100. PubMed ID: 9707850
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
    Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
    Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the development of a vaccine against dengue].
    Guzmán MG
    Acta Cient Venez; 1998; 49 Suppl 1():38-45. PubMed ID: 10030053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue: the killer.
    Talib VH; Verma SK; Dhupia JS
    Indian J Pathol Microbiol; 1997 Jan; 40(1):1-2. PubMed ID: 9145603
    [No Abstract]   [Full Text] [Related]  

  • 11. Dengue, one of the great emerging health challenges of the 21st century.
    Guzmán M; Kourí G; Díaz M; Llop A; Vazquez S; González D; Castro O; Alvarez A; Fuentes O; Montada D; Padmanabha H; Sierra B; Pérez A; Rosario D; Pupo M; Díaz C; Sanchez L
    Expert Rev Vaccines; 2004 Oct; 3(5):511-20. PubMed ID: 15485330
    [No Abstract]   [Full Text] [Related]  

  • 12. Dengue: emergence as a global public health problem and prospects for control.
    Jacobs M
    Trans R Soc Trop Med Hyg; 2000; 94(1):7-8. PubMed ID: 10748886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue viral infections.
    Malavige GN; Fernando S; Fernando DJ; Seneviratne SL
    Postgrad Med J; 2004 Oct; 80(948):588-601. PubMed ID: 15466994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vaccines approach the finish line.
    Edelman R
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue vaccines: problems and prospects.
    Chaturvedi UC; Shrivastava R; Nagar R
    Indian J Med Res; 2005 May; 121(5):639-52. PubMed ID: 15937367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
    Kitchener S; Nissen M; Nasveld P; Forrat R; Yoksan S; Lang J; Saluzzo JF
    Vaccine; 2006 Feb; 24(9):1238-41. PubMed ID: 16213632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue and dengue vaccines.
    Edelman R
    J Infect Dis; 2005 Mar; 191(5):650-3. PubMed ID: 15688277
    [No Abstract]   [Full Text] [Related]  

  • 18. Dengue virus: break-bone fever.
    Clarke T
    Nature; 2002 Apr; 416(6882):672-4. PubMed ID: 11961522
    [No Abstract]   [Full Text] [Related]  

  • 19. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deadly dengue: new vaccines promise to tackle this escalating global menace.
    Shekhar C
    Chem Biol; 2007 Aug; 14(8):871-2. PubMed ID: 17719483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.